Delivery Order SPE2DB24D2101-SPE2DB25FKNKY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,563.86 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Yuvafem 10 micrograms vaginal inserts (18 units) under a firm fixed-price contract valued at $1,741.75. This is a non-set-aside competitive award with an ultimate completion date of August 12, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.73 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 13, 2025, with completion scheduled for August 14, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, procured through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.71 to AmerisourceBergen Drug Corp on August 11, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical...
- The Defense Logistics Agency awarded a $2,650.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award was made without a set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $3,607.76 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, classified as a non-set-aside award, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,285.89 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (8-count package) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,057.01 to AmerisourceBergen Drug Corp on August 15, 2025, for Yuvafem 10 micrograms vaginal insert (18 units). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction within the federal pharmaceutical supply chain. The contract is set to complete by August 18, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $15,285.96 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18-count) on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,462.37 order is for the supply of YUVAFEM 10 MCG vaginal inserts. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a period of performance through December 31,...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNKYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,602.37 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (8 count) under a firm fixed price contract. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements, consistent with DLA's mission to provide logistics support to the Department of Defense and other federal healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive federal contract portfolio with DLA covering diverse therapeutic domains and product categories, demonstrating the company's capability to fulfill competitive federal procurement requirements across multiple healthcare delivery channels.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/13/25 |